It is a pharma public limited company based in Vadodara, Gujarat, India, established in 1988.
1988 | Vadodara, Gujarat, India | ActiveUnimed Investments Limited, a active public limited company, was established on 27 January 1988 in Vadodara, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U65999GJ1988PLC010304. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.42 Cr.
Formerly known as Unimed Technologies Private Limited, Unimed Technologies Limited. It upholds a compliant status. Its leadership includes Vivek Mittal (Director), Swati Chetan Jagetia (Director), Rajiv Chhelshankar Pandya (Director). Past directors included Chandrakant Khubchandbhai Agrawal, Vivek Mittal, Suresh Kumar Ajmera. It holds ₹7.50 Cr open charges and no settled loans. Its latest AGM occurred on 21 August 2025, with the balance sheet filed on 31 March 2025. It is based at Ground Floor, Synergy House No. 1, Subhanpura Road, Vadodara, Vadodara, Gujarat, 390003.
U65999GJ1988PLC010304
010304
27 January 1988
₹3.00 Cr
₹1.42 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Unimed Investments Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Mittal | Director | 20 May 2019 | Current |
| Swati Chetan Jagetia | Director | 23 Apr 2025 | Current |
| Rajiv Chhelshankar Pandya | Director | 09 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Aug 2010 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2019 | Past |
| Pramod Abcsdd | Director | 23 Apr 2025 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2010 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 May 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unimed Investments Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 202.7% increase. The company also saw a substantial improvement in profitability, with a 27.27% increase in profit. The company's net worth Soared by an impressive increase of 15.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Unimed Investments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹75,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2000 | Icici Bank Limited | ₹7.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Unimed Investments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Unimed Investments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimed Investments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Unimed Investments Limited last Annual general meeting of members was held on 21 Aug 2025 as per latest MCA records. was documented.
Progress on Swati Chetan Jagetia was appointed as a Director was appointed as a Director on 23 Apr 2025 & has been associated with this company since 7 months 7 days . was documented.
Unimed Investments Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
The activity Rajiv Chhelshankar Pandya was appointed as a Director was appointed as a Director on 09 Feb 2024 & has been associated with this company since 1 year 9 months . was completed.
Progress on Vivek Mittal was appointed as a Director was appointed as a Director on 20 May 2019 & has been associated with this company since 6 years 6 months . was documented.
A charge with Icici Bank Limited of Rs. 7.50 Cr registered on 06 May 2000 with Charge ID 90099189 was modified on 05 May 2006. was recorded as a recent event.
The CIN of Unimed Investments Limited is U65999GJ1988PLC010304.
Unimed Investments Limited is headquartered at Ground Floor, Synergy House No. 1, Subhanpura Road, Vadodara, Vadodara, Gujarat, 390003.
Unimed Investments Limited was incorporated on 27 January 1988.
The current directors of Unimed Investments Limited are
The primary industry of Unimed Investments Limited is Trade.
Unimed Investments Limited is unlisted.
The authorized capital of Unimed Investments Limited is ₹3.00 Cr, and the paid-up capital is ₹1.42 Cr.
The compliance status of Unimed Investments Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX